Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-31

Clinical Trial Update: The Effect of Adjunctive Melatonin With Colistin in Patients With Multidrug-Resistant Gram-Negative Bacterial Infections [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating adjunctive melatonin with colistin for multidrug-resistant Gram-negative bacterial infections, currently not yet recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Colistin (colistin)
  • Melatonin (melatonin)

Snippet

Sponsor: Ain Shams University | Conditions: Multidrug-Resistant Gram-Negative Bacterial Infections, Antimicrobial Resistance | Phase 3 | Status: NOT_YET_RECRUITING